Comorbidities in hidradenitis suppurativa: Role of metabolic syndrome and sexual dysfunction disorders in postoperative healing
To the Editor: Hidradenitis suppurativa (HS) is a chronic painful inflammatory folliculitis which has been associated with numerous co-morbidities such as obesity, metabolic syndrome, smoking, and autoimmune diseases in the literature.1,2 These comorbidities contribute to systemic inflammation and immunologic dysfunction that worsen the pathogenesis of the disease.3 In cases of severe disease (Hurley Stage III), surgical intervention including wide local excision is required for treatment.1
Authors
- Sowmya Ravi (ORCID: https://orcid.org/0000-0002-0370-3014)
- Emily Coleman (ORCID: https://orcid.org/0000-0001-6936-4396)
- Joshua Epstein (ORCID: https://orcid.org/0000-0002-8553-1358)
- Abigail E. Chaffin (ORCID: https://orcid.org/0000-0001-6446-7142)
- Dylan T. Wolff (ORCID: https://orcid.org/0000-0003-4897-9732)
- Tatjana Mortell (ORCID: https://orcid.org/0000-0002-0952-4930)
Institutions
- Tulane University (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- JAAD International
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1016/j.jdin.2024.09.006
- Citations
- 1
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.53